These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34961945)

  • 1. Evaluation of solvent/detergent-treated plasma safety and efficacy in orthotopic liver transplant and thrombotic thrombocytopenic purpura patients: A single center experience.
    McRae HL; Milito C; Klapheke CA; Refaai MA
    Transfusion; 2022 Feb; 62(2):429-438. PubMed ID: 34961945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent-Detergent Plasma for the Treatment of Thrombotic Microangiopathies: A Canadian Tertiary Care Centre Experience.
    Lee LJ; Roland KJ; Sreenivasan GM; Zypchen LN; Ambler KLS; Yenson PR
    Transfus Apher Sci; 2018 Apr; 57(2):233-235. PubMed ID: 29496401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange therapy for thrombotic thrombocytopenic purpura in pediatric patients with liver transplantation.
    Lee CH; Chen CL; Lin CC; Yang CH; Cheng YF; Wang MC; Eng HL; Liu PP; Chuang FR
    Transplant Proc; 2008 Oct; 40(8):2554-6. PubMed ID: 18929799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience.
    Edel E; Al-Ali HK; Seeger S; Kauschat D; Matthes G
    Transfus Med Hemother; 2010 Feb; 37(1):13-19. PubMed ID: 20737012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ADAMTS13 and Von Willebrand factor levels and activities, and plasminogen levels, in plasma products currently available for the treatment of thrombotic thrombocytopenic purpura in South Africa.
    van Marle AC; Joubert J; Meiring SM
    Transfus Apher Sci; 2019 Feb; 58(1):72-78. PubMed ID: 30551950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
    Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
    J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available.
    Horowitz MS; Pehta JC
    Vox Sang; 1998; 74 Suppl 1():231-5. PubMed ID: 9789534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).
    Zeigler ZR; Shadduck RK; Gryn JF; Rintels PB; George JN; Besa EC; Bodensteiner D; Silver B; Kramer RE;
    J Clin Apher; 2001; 16(1):19-22. PubMed ID: 11309826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
    Michael M; Elliott EJ; Ridley GF; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003595. PubMed ID: 19160220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura.
    Hou R; Tian W; Qiao R; Zhang J
    J Clin Apher; 2020 Jun; 35(3):154-162. PubMed ID: 32110837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery.
    Haubelt H; Blome M; Kiessling AH; Isgro F; Bach J; Saggau W; Hellstern P
    Vox Sang; 2002 Jan; 82(1):9-14. PubMed ID: 11856461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura.
    Evans G; Llewelyn C; Luddington R; Baglin TP; Williamson LM
    Clin Lab Haematol; 1999 Apr; 21(2):119-23. PubMed ID: 10342071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.
    Rock G; Clark WF; Anderson D; Benny B; Sutton D; Leblond P; Sternbach M; Sontrop J;
    Thromb Res; 2013 Apr; 131(4):308-12. PubMed ID: 23411128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
    Garraud O; Malot S; Herbrecht R; Ojeda-Uribe M; Lin JS; Veyradier A; Payrat JM; Liu K; Corash L; Coppo P
    Transfus Apher Sci; 2019 Dec; 58(6):102665. PubMed ID: 31740165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during Orthotopic Liver Transplantation.
    Freeman JW; Williamson LM; Llewelyn C; Fisher N; Allain JP; Bellamy M; Baglin TP; Klinc J; Ala FA; Smith N; Neuberger J; Wreghitt T
    Vox Sang; 1998; 74 Suppl 1():225-9. PubMed ID: 9789533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.
    Alvarez-Larrán A; Del Río J; Ramírez C; Albo C; Peña F; Campos A; Cid J; Muncunill J; Sastre JL; Sanz C; Pereira A
    Vox Sang; 2004 May; 86(4):246-51. PubMed ID: 15144529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes.
    Barz D; Budde U; Hellstern P
    Thromb Res; 2002 Oct; 107 Suppl 1():S23-7. PubMed ID: 12379289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura.
    Tse B; Lim G; Sholzberg M; Pavenski K
    J Thromb Haemost; 2020 Nov; 18(11):2870-2877. PubMed ID: 33448602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of thrombotic thrombocytopenic purpura.
    Fontana S; Kremer Hovinga JA; Lämmle B; Mansouri Taleghani B
    Vox Sang; 2006 May; 90(4):245-54. PubMed ID: 16635066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.